- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Marksans Pharma covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (56), financial health (95), director (45) and company-foundation signals.
- Operating for 34+ years.
- Company status is Active as per MCA.
- Annual filings up to date (balance sheet as of Mar 2025).
- Profitable in FY 2023.
- Positive net worth.
- 13 directors on the board.
- Director ABHINNA MOHANTY SUNDAR has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Marksans Pharma
Marksans Pharma is an MCA-registered Indian company: a Public Limited Indian Non-Government Company (CIN L24110MH1992PLC066364). Business overview includes Pharma (Drug Formulation & Development), incorporated on April 16, 1992 (34+ years old), headquartered in Mumbai, Maharashtra, India. The company is currently Active with Active Compliant compliance status.
- Location 11Th Floor, Grandeur, Veera Desai Extension Road Oshiwara, Andheri (W), Mumbai, Maharashtra - 400053
- Website marksanspharma.com
Financial Performance of Marksans Pharma
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Marksans Pharma (13)
Charges of Marksans Pharma
| Lender | Amount | Status |
|---|---|---|
|
State Bank Of India
Creation Date: 07 Sep 2017 |
66.80 cr | Closed |
|
State Bank Of India
Creation Date: 23 Jun 2015 |
44.41 cr | Closed |
|
Bank Of India
Creation Date: 23 Dec 2013 |
4.00 cr | Closed |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
